ADME Properties Evaluation in Drug Discovery: Prediction of Caco-2 Cell Permeability Using a Combination of NSGA-II and Boosting

被引:165
作者
Wang, Ning-Ning [1 ]
Dong, Jie [1 ]
Deng, Yin-Hua [1 ]
Zhu, Min-Feng [2 ]
Wen, Ming [3 ]
Yao, Zhi-Jiang [1 ,3 ]
Lu, Ai -Ping [4 ]
Wang, Jian-Bing [3 ]
Cao, Dong-Sheng [1 ,4 ]
机构
[1] Cent S Univ, Sch Pharmaceut Sci, Changsha 410013, Hunan, Peoples R China
[2] Cent S Univ, Sch Math & Stat, Changsha 410083, Hunan, Peoples R China
[3] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China
[4] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
MULTIPLE LINEAR-REGRESSION; IN-SILICO PREDICTIONS; PARTIAL LEAST-SQUARES; MEMBRANE-PERMEABILITY; GENETIC ALGORITHM; INTESTINAL-ABSORPTION; APPLICABILITY DOMAIN; MOLECULAR-SURFACE; QSAR; VALIDATION;
D O I
10.1021/acs.jcim.5b00642
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Caco-2 cell monolayer model is a popular surrogate in predicting the in vitro human intestinal permeability of a drug due to its morphological and functional similarity with human enterocytes. A quantitative structure property relationship (QSPR) study was carried out to predict Caco-2 cell permeability of a large data set consisting of 1272 compounds. Four different methods including multivariate linear regression (MLR), partial least-squares (PLS), support vector machine (SVM) regression and Boosting were employed to build prediction models with 30 molecular descriptors selected by nondominated sorting genetic algorithm-II (NSGA-II). The best Boosting model was obtained finally with R-2 = 0.97, RMSEF = 0.12, Q(2) = 0.83, RMSECV = 0.31 for the training set and R-T(2) = 0.81, RMSET = 0.31 for the test set. A series of validation methods were used to assess the robustness and predictive ability of our model according to the OECD principles and then define its applicability domain. Compared with the reported QSAR/QSPR models about Caco-2 cell permeability, our model exhibits certain advantage in database size and prediction accuracy to some extent. Finally, we found that the polar volume, the hydrogen bond donor, the surface area and some other descriptors can influence the Caco-2 permeability to some extent. These results suggest that the proposed model is a good tool for predicting the permeability of drug candidates and to perform virtual screening in the early stage of drug development.
引用
收藏
页码:763 / 773
页数:11
相关论文
共 82 条
[1]   Theoretically-derived molecular descriptors important in human intestinal absorption [J].
Agatonovic-Kustrin, S ;
Beresford, R ;
Yusof, APM .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 25 (02) :227-237
[2]   P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: The influence of culturing conditions and drug exposure on P-gp expression levels [J].
Anderle, P ;
Niederer, E ;
Rubas, W ;
Hilgendorf, C ;
Spahn-Langguth, H ;
Wunderli-Allenspach, H ;
Merkle, HP ;
Langguth, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (06) :757-762
[3]  
[Anonymous], 1997, CRIT REV THER DRUG C
[4]   Caco-2 monolayers in experimental and theoretical predictions of drug transport (Reprinted from Advanced Drug Delivery Reviews, vol 22, pg 67-84, 1996) [J].
Artursson, P ;
Palm, K ;
Luthman, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :27-43
[5]   Caco-2 permeability of weakly basic drugs predicted with the Double-Sink PAMPA pKaflux method [J].
Avdeef, A ;
Artursson, P ;
Neuhoff, S ;
Lazorova, L ;
Gråsjö, J ;
Tavelin, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (04) :333-349
[6]   PAMPA - Critical factors for better predictions of absorption [J].
Avdeef, Alex ;
Bendels, Stefanie ;
Di, Li ;
Faller, Bernard ;
Kansy, Manfred ;
Sugano, Kiyohiko ;
Yamauchi, Yukinori .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (11) :2893-2909
[7]   Cross-validation as the objective function for variable-selection techniques [J].
Baumann, K .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2003, 22 (06) :395-406
[8]   In silico predictions of drug solubility and permeability:: Two rate-limiting barriers to oral drug absorption [J].
Bergström, CAS .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) :156-161
[9]  
Bohets Hilde, 2001, Current Topics in Medicinal Chemistry, V1, P367, DOI 10.2174/1568026013394886
[10]  
Cabrera-Pérez MA, 2012, MINI-REV MED CHEM, V12, P534